Global control of hepatitis C: where challenge meets opportunity
about
IFNL3 mRNA structure is remodeled by a functional non-coding polymorphism associated with hepatitis C virus clearancePharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal ImpairmentHepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagyModeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infectionsStudying the immune response to human viral infections using zebrafishHepatitis C Virus in North Africa: An Emerging ThreatInterferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burdenRational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus InfectionPrevalence of Equine Hepacivirus Infections in France and Evidence for Two Viral Subtypes Circulating WorldwideVinexin β Interacts with Hepatitis C Virus NS5A, Modulating Its Hyperphosphorylation To Regulate Viral Propagation.Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Bridging the data gaps in the epidemiology of hepatitis C virus infection in Malaysia using multi-parameter evidence synthesisLong-term functional duration of immune responses to HCV NS3/4A induced by DNA vaccination.Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world settingReversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?Protective immunity against hepatitis C: many shades of gray.Hepcidin and the iron enigma in HCV infection.Aryl-substituted aminobenzimidazoles targeting the hepatitis C virus internal ribosome entry site.Quinolinate Phosphoribosyltransferase is an Antiviral Host Factor Against Hepatitis C Virus Infection.A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compoundRegulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation.Endoplasmic reticulum stress links hepatitis C virus RNA replication to wild-type PGC-1α/liver-specific PGC-1α upregulationPersistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized miceImmune control and failure in HCV infection--tipping the balance.Increased numbers of CD5+CD19+CD1dhighIL-10+ Bregs, CD4+Foxp3+ Tregs, CD4+CXCR5+Foxp3+ follicular regulatory T (TFR) cells in CHB or CHC patients.Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Gene expression profiling to predict and assess the consequences of therapy-induced virus eradication in chronic hepatitis C virus infection.Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.Will there be a vaccine to prevent HCV infection?Hepatitis C virus antibody prevalence, demographics and associated factors among persons screened at Hawai'i community-based health settings, 2010-2013.miR-122 stimulates hepatitis C virus RNA synthesis by altering the balance of viral RNAs engaged in replication versus translationHCV and HIV co-infection: mechanisms and management.Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathwayPrevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients.Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons.Dissecting the roles of the 5' exoribonucleases Xrn1 and Xrn2 in restricting hepatitis C virus replication.Transmission of Hepatitis C Virus among Prisoners, Australia, 2005-2012.
P2860
Q22121973-B6D66DBF-1F60-4B0A-88EF-E866803781ECQ26751452-EF6D21BB-0996-4B40-A585-89A0B82B5368Q26801207-3BB14837-7AC7-48DA-AD9B-BE0854D7EFDBQ27002381-84406716-AD13-4A82-8411-D7A95B26B407Q27002635-D97259D0-8696-4A93-BF88-4DD9F8B93EC2Q28069590-E893F905-2B35-4951-AC9D-849B6554CA0AQ28255239-E9D3F483-4E88-4E4E-B462-E969F908AAAAQ28545971-ACF6D508-38DF-413A-BC8C-110587A20C53Q29029564-E4C2A487-605D-4A98-B8D1-E57985ACFA18Q30009166-DEC50A1F-1E2C-46E5-8FB5-8C9085D29AE3Q30386551-6993E481-5115-4590-80AA-F9509F162026Q30868237-FE8E8E61-C09B-4CB2-B6FF-831636FB694EQ33390630-B11FF41C-BCDC-454E-8364-FFD76487C6FFQ33646482-830B057A-FBF9-42D6-B694-59A5453806A0Q33731308-971DD896-57C2-4D0B-9AC6-E2206B544630Q33759224-C0288192-BDEC-4C04-BB06-082A0AD75BC3Q33779089-7DAF6490-883D-41AD-9F33-EA2093BE3C58Q33893998-60D9E380-B873-4505-B565-EB2C48E57D08Q33918411-B2E104AF-DBB4-42EA-9880-9EC707FBC32DQ33918841-E5DC3D1A-1215-430C-8741-B238B48586FDQ34020915-38E49B03-1427-40D9-B9E7-0619EE88F57FQ34057855-36174AD5-9A1B-4BE0-9A09-33B8C27D8946Q34124403-E014BE4F-8235-47CA-9320-499539C3DFA1Q34178628-399B1C99-0514-4E45-8DB9-1765B52631E6Q34235321-E284C675-DA80-44B5-AD77-03F6DB674AE8Q34470890-7BA6C900-6CA2-4877-87D5-D1391FCDD8B8Q34481429-995384EF-FC62-4DB7-B865-DD758477D77BQ34593704-BD0400CD-52E8-4A41-93E3-31B15AF1578DQ34594986-8857BCE8-9F32-4B27-9CF4-0F7181A063A5Q34781537-26CABD3C-04A3-44D7-B87E-D8158211BE57Q34990715-3F1D0CDB-8E45-4D67-B78C-65F0FF067FC8Q35079438-694294E5-1A92-4EB4-A525-B88FF0E34960Q35090634-78268A65-14D2-43BA-9E34-5A14798D036FQ35096951-DFF1B3A9-66BE-4423-B2C4-3ADC1ED8A52CQ35111044-D9F6064E-C81F-445E-8367-3E7209D1B344Q35235877-6A16801B-A16E-4E5C-8172-E5F0AEC5CEEFQ35473208-2A18943F-3049-4BAC-B1DB-1074E7BD8222Q35488054-23D4404E-6A27-4A27-8939-2E345647A37EQ35488499-DA0E9D47-2704-43AF-845C-BAAC0D2EAE1DQ35551683-9F12DD16-DE78-4577-90FD-20E538A2A53D
P2860
Global control of hepatitis C: where challenge meets opportunity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Global control of hepatitis C: where challenge meets opportunity
@en
Global control of hepatitis C: where challenge meets opportunity.
@nl
type
label
Global control of hepatitis C: where challenge meets opportunity
@en
Global control of hepatitis C: where challenge meets opportunity.
@nl
prefLabel
Global control of hepatitis C: where challenge meets opportunity
@en
Global control of hepatitis C: where challenge meets opportunity.
@nl
P2860
P356
P1433
P1476
Global control of hepatitis C: where challenge meets opportunity
@en
P2093
David L Thomas
P2860
P2888
P304
P356
10.1038/NM.3184
P407
P577
2013-07-01T00:00:00Z